CV Sciences Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,300.20
1,312.00
12,233.10
14,141.30
4,897.10
10,001
Depreciation, Depletion & Amortization
767.30
933.60
1,012.30
1,052.60
182.80
519
Other Funds
174.80
0.30
-
250.00
-
3,320
Funds from Operations
606.00
43.10
2,279.00
3,139.00
1,478.40
13,830
Changes in Working Capital
4,273.20
6,755.10
1,929.30
1,085.30
2,136.60
1,271
Net Operating Cash Flow
4,879.20
6,712.00
4,208.30
2,053.70
3,615.00
12,559
Capital Expenditures
226.60
449.20
113.50
17.20
2,000.40
Sale of Fixed Assets & Businesses
950.00
-
-
10.40
-
Purchase/Sale of Investments
750.00
-
-
-
-
Net Investing Cash Flow
1,875.80
1,384.40
1,742.80
852.70
2,000.40
Issuance/Reduction of Debt, Net
6,092.10
92.10
1,647.10
1,990.10
119.50
Net Financing Cash Flow
8,998.30
8,155.10
4,167.10
1,740.10
119.50
Net Change in Cash
2,243.20
58.70
1,784.00
539.00
1,734.10
Free Cash Flow
5,105.80
7,161.20
4,321.80
2,071.00
1,614.60
Deferred Taxes & Investment Tax Credit
-
-
-
-
481.50
10
Net Assets from Acquisitions
50.80
-
250.00
-
-
Other Sources
-
264.80
623.70
859.50
-
Change in Capital Stock
2,731.40
8,247.50
2,520.00
-
-
Other Uses
-
1,200.00
2,002.90
-
-

About CV Sciences

View Profile
Address
2688 South Rainbow Boulevard
Las Vegas Nevada 89146
United States
Employees -
Website http://www.cvsciences.com
Updated 07/08/2019
CV Sciences, Inc. engages in the provision of consumer and pharmaceutical products. It offers nutraceutical, beauty care, specialty foods, vape, and other. It operates through the Consumer Products, and Specialty Pharmaceutical segments.